VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Sunday, January 11, 2026

Wide Moat Stocks Expansion-Stage Stocks Home My Collections

Stock Comparison

InterContinental Hotels Group PLC vs Roche Holding AG

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

InterContinental Hotels Group PLC

IHG · London Stock Exchange

Market cap (USD)$18.8B

Gross margin (TTM)—

Operating margin (TTM)—

Net margin (TTM)—

SectorConsumer

Industry—

CountryGB

Data as of2026-01-10

Moat score

57/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into InterContinental Hotels Group PLC's moat claims, evidence, and risks.

View IHG analysis

Roche Holding AG

ROG · SIX Swiss Exchange

Market cap (USD)$271.4B

Gross margin (TTM)73.6%

Operating margin (TTM)29.1%

Net margin (TTM)15.4%

SectorHealthcare

IndustryDrug Manufacturers - General

CountryCH

Data as of2025-12-28

Moat score

68/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Roche Holding AG's moat claims, evidence, and risks.

View ROG analysis

Comparison highlights

Moat score gap: Roche Holding AG leads (68 / 100 vs 57 / 100 for InterContinental Hotels Group PLC).
Segment focus: InterContinental Hotels Group PLC has 5 segments (36% in Fee business (franchise, management and ancillary fees)); Roche Holding AG has 2 segments (76.3% in Pharmaceuticals).
Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
Moat breadth: InterContinental Hotels Group PLC has 8 moat types across 3 domains; Roche Holding AG has 5 across 3.

Primary market context

InterContinental Hotels Group PLC

Fee business (franchise, management and ancillary fees)

Market

Branded hotel franchising and management services

Geography

Global

Customer

Hotel owners and developers

Role

Franchisor and hotel manager (asset-light brand platform)

Revenue share

36%

Roche Holding AG

Pharmaceuticals

Market

Innovative (branded) prescription pharmaceuticals

Geography

Global

Customer

Healthcare providers and systems (hospitals/clinics), payers/governments, and patients

Role

Innovator pharmaceutical developer, manufacturer and marketer

Revenue share

76.3%

Side-by-side metrics

InterContinental Hotels Group PLC

Roche Holding AG

Ticker / Exchange

IHG - London Stock Exchange

ROG - SIX Swiss Exchange

Market cap (USD)

$18.8B

$271.4B

Gross margin (TTM)

n/a

73.6%

Operating margin (TTM)

n/a

29.1%

Net margin (TTM)

n/a

15.4%

Sector

Consumer

Healthcare

Industry

n/a

Drug Manufacturers - General

HQ country

Primary segment

Fee business (franchise, management and ancillary fees)

Pharmaceuticals

Market structure

Oligopoly

Competitive

Market share

n/a

HHI estimate

n/a

Pricing power

Moderate

Moat score

57 / 100

68 / 100

Moat domains

Demand, Supply, Network

Legal, Supply, Demand

Last update

2026-01-10

2025-12-28

Moat coverage

Shared moat types

No overlap yet.

InterContinental Hotels Group PLC strengths

Brand TrustScale Economies Unit CostLong Term ContractsTwo Sided NetworkDistribution ControlPass-through reimbursement revenueAsset-heavy hotel operations (limited moat)Immaterial ancillary activity

Roche Holding AG strengths

IP Choke PointCapex Knowhow ScaleInstalled Base ConsumablesData Workflow LockinRegulated Standards Pipe

Segment mix

InterContinental Hotels Group PLC segments

Full profile >

Fee business (franchise, management and ancillary fees)

Oligopoly

36%

System Fund (marketing, reservations and loyalty assessments)

Monopoly

32.7%

Reimbursable revenues (managed hotel staff reimbursements)

Competitive

20.3%

Owned, leased and managed lease hotels

Competitive

10.5%

Insurance activities (ancillary)

Competitive

0.5%

Roche Holding AG segments

Full profile >

Pharmaceuticals

Competitive

76.3%

Diagnostics

Oligopoly

23.7%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.